Fundraising FoxLifespan Vision Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Paulex Bio is developing an oral medicine aimed at regenerating beta cells to address the underlying cause of type 1 and type 2 diabetes.
BiotechDigital HealthLa Jolla, US
Sanjuan Miguel(Chief Executive Officer)in
BoardEdgardo Rayo(Director)Mohammad Hayat(Director)Francisco Leon(Director)in
Sift Biosciences develops T-cell immunotherapies for cancer and autoimmune diseases, using an AI-driven discovery platform combined with metagenomics and high-throughput cellular screening to identify microbially derived molecules that activate memory T cells.
AI & Machine LearningBiotechHealthtechSan Carlos, US
Yue Clare Lou(Co-Founder & CEO)in
BoardKevin Barrett(Director)inAltar Munis(Director)
Co-investorsEisai Innovation, Inc.SBI HoldingsFifty YearsFREEFLOW
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.